Immune Repertoire Sequencing Market Report 2025 (Global Edition)

Global Immune Repertoire Sequencing Market Report 2025 Market Size Split by Product Type Outlook: (Assay Kits, Instruments), by Application Outlook: (Cancer Immunotherapy, Biomarker Discovery, Autoimm...

Immune Repertoire Sequencing Market Report Description

We have various report editions of Immune Repertoire Sequencing Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Immune Repertoire Sequencing Market Insights Video

Competitive Landscape of the Immune Repertoire Sequencing Market

The Immune Repertoire Sequencing Market is highly competitive, with several key players and emerging companies vying for market share. The competitive dynamics are driven by the increasing demand for immune profiling in personalized medicine, cancer immunotherapy, and infectious disease research. These companies are focused on advancing sequencing technologies, improving the accuracy and efficiency of immune repertoire sequencing, and expanding their product offerings to cater to various research and clinical applications.

In August 2024, Illumina launched its MiSeq i100 Series which is designed to simplify Next-Generation Sequencing (NGS) applications, including immune repertoire sequencing, making it faster and more accessible. This new product targets a broad range of research, from oncology to genetic testing. (Source: https://www.illumina.com/company/news-center/press-releases/press-release-details.html?newsid=808df13c-52d9-4012-b1b9-17deac6dcd0a) In November 2024, Thermo Fisher introduced the Ion S5 System, which significantly enhances genomic sequencing speed and accuracy. The platform is particularly relevant for immune repertoire sequencing as it supports high-throughput and comprehensive genetic analysis. (Source: https://www.thermofisher.com/us/en/home/life-science/sequencing/next-generation-sequencing/instruments/ion-genestudio-system.html)

Top Companies Market Share in Immune Repertoire Sequencing Industry: (In no particular order of Rank)

• Illumina Inc.
• Thermo Fisher Scientific
• PacBio
• CD Genomics
• Agilent Technologies
• Inc.
• F. Hoffmann-La Roche Ltd.
• BGI Group Guangdong
• Takara Bio
• Inc.
• Adaptive Biotechnologies
• Juno Therapeutics
• Atreca
• Inc.
• irepertoire
• Inc
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Immune Repertoire Sequencing Market

Which Region Dominates the Immune Repertoire Sequencing Market in 2024?

According to Cognitive Market Research, North America dominates the Immune Repertoire Sequencing (IRS) market due to several key factors, including advanced healthcare infrastructure, significant research funding, and a high concentration of biotechnology companies. The region benefits from a strong focus on immunology research and development, driven by both public and private investment. Additionally, North America has a large number of academic institutions and research organizations dedicated to immune system studies, leading to innovations in immune repertoire sequencing technologies.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is the fastest-growing region in the Immune Repertoire Sequencing (IRS) market due to rapid advancements in biotechnology, increasing healthcare investments, and rising demand for personalized medicine. Countries like China, Japan, and India are witnessing significant growth in immunology research, driven by a surge in healthcare infrastructure development and government support for life sciences.

The current report Scope analyzes Immune Repertoire Sequencing Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Immune Repertoire Sequencing

According to Cognitive Market Research, the global Immune Repertoire Sequencing market size was estimated at USD 172.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 69.00 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.1% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Immune Repertoire Sequencing market with a market size of USD 54.44 million in 2024 and is projected to grow at a CAGR of 5.9% during the forecast period. The U.S. market's advanced healthcare infrastructure, a strong presence of biopharmaceutical companies.
• The Canada Immune Repertoire Sequencing market had a market share of USD 8.28million in 2024 and is projected to grow at a CAGR of 6.9% during the forecast period. Canada’s rising advanced healthcare infrastructure, a strong presence of biopharmaceutical companies.
• The Mexico Immune Repertoire Sequencing market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD 6.28 million in 2024.

Europe Immune Repertoire Sequencing

According to Cognitive Market Research, the global Immune Repertoire Sequencing market size was estimated at USD 172.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 51.75 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031.

• The United Kingdom Immune Repertoire Sequencing market had a market share of USD 8.69million in 2024 and is projected to grow at a CAGR of 6.1%during the forecast period. In the UK, Immune Repertoire Sequencing sales witness an upswing due to the strong healthcare infrastructure, extensive research programs.
• The France Immune Repertoire Sequencing market is projected to witness growth at a CAGR of 5.6%during the forecast period, with a market size of USD 4.76million in 2024.
• According to Cognitive Market Research, the German Immune Repertoire Sequencing market size was valued at USD 10.25million in 2024 and is projected to grow at a CAGR of 6.6%during the forecast period. In Germany, Immune Repertoire Sequencing surged due to the strong healthcare infrastructure, extensive research programs.
• The Italy Immune Repertoire Sequencing market is projected to witness growth at a CAGR of 5.8%during the forecast period, with a market size of USD 4.45million in 2024.
• The Russia Immune Repertoire Sequencing market is projected to witness growth at a CAGR of5.4%during the forecast period, with a market size of USD 8.02million in 2024.
• The Spain Immune Repertoire Sequencing market is projected to witness growth at a CAGR of 5.5%during the forecast period with a market size of USD 4.24million in 2024
• The Luxembourg Immune Repertoire Sequencing market is projected to witness growth at a CAGR of 6.5%during the forecast period, with a market size of USD 1.60 million in 2024.
• The Portugal Immune Repertoire Sequencing market is projected to witness growth at a CAGR of 6.2%during the forecast period, with a market size of USD 1.09 million in 2024.
• The Greece Immune Repertoire Sequencing market is projected to witness growth at a CAGR of 6.7%during the forecast period, with a market size of USD 0.62 million in 2024.
• The Rest of Europe's Immune Repertoire Sequencing market is projected to witness growth at a CAGR of 5.1%during the forecast period, with a market size of USD 8.02 million in 2024.

Asia Pacific Immune Repertoire Sequencing

According to Cognitive Market Research, the global Immune Repertoire Sequencing market size was estimated at USD 172.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 39.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.9% from 2024 to 2031.

• According to Cognitive Market Research, the China Immune Repertoire Sequencing market size was valued at USD 17.85million in 2024 and is projected to grow at a CAGR of 9.4%during the forecast period. Immune Repertoire Sequencing surged in China due to expanding healthcare investments, increased research activity.
• The Japan Immune Repertoire Sequencing market is projected to witness growth at a CAGR of 7.3%during the forecast period, with a market size of USD 5.48million in 2024.
• The India Immune Repertoire Sequencing market had a market share of USD 4.76million in 2024 and is projected to grow at a CAGR of 11.7%during the forecast period. India's expanding healthcare investments, increased research activity.
• The South Korean Immune Repertoire Sequencing market is projected to witness growth at a CAGR of 9.0%during the forecast period, with a market size of USD 3.97million in 2024.
• The Australian Immune Repertoire Sequencing market is projected to witness growth at a CAGR of 9.6%during the forecast period, with a market size of USD 2.06million in 2024.
• The South East Asia Immune Repertoire Sequencing market is projected to witness growth at a CAGR of 10.9%during the forecast period, with a market size of USD 2.74million in 2024.
• The Rest of Asia Pacific Immune Repertoire Sequencing market is projected to witness growth at a CAGR of 9.7%during the forecast period, with a market size of USD 2.82million in 2024.

South America Immune Repertoire Sequencing

According to Cognitive Market Research, the global Immune Repertoire Sequencing market size was estimated at USD 172.5 Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD 8.63 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Immune Repertoire Sequencing market size was valued at USD 3.69million in 2024 and is projected to grow at a CAGR of 7.9%during the forecast period. Immune Repertoire Sequencings flourished in Brazil due to increasing healthcare investments, advancements in research capabilities.
• Argentina's Immune Repertoire Sequencing market had a market share of USD 1.45million in 2024 and is projected to grow at a CAGR of 8.2%during the forecast period. Argentina's increasing healthcare investments, advancements in research capabilities.
• Colombia Immune Repertoire Sequencing market is projected to witness growth at a CAGR of 7.1% during the forecast period, with a market size of USD 0.77million in 2024.
• Peru Immune Repertoire Sequencing market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 0.71million in 2024.
• Chile Immune Repertoire Sequencing market is projected to witness growth at a CAGR of 7.6%during the forecast period, with a market size of USD 0.62 million in 2024.
• The Rest of Latin America's Immune Repertoire Sequencing market is projected to witness growth at a CAGR of 6.4% during the forecast period, with a market size of USD 1.39 million in 2024.

Middle East and Africa Immune Repertoire Sequencing

According to Cognitive Market Research, the global Immune Repertoire Sequencing market size was estimated at USD 172.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 3.45 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.6% from 2024 to 2031..

• The GCC Countries Immune Repertoire Sequencing market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 1.48million in 2024. Immune Repertoire Sequencing sales flourish due to the expanding healthcare infrastructure, increasing investments in biotechnology.
• The Egypt Immune Repertoire Sequencing market is projected to witness growth at a CAGR of 7.9% during the forecast period, with a market size of USD 0.36million in 2024.
• The South Africa Immune Repertoire Sequencing market is projected to witness growth at a CAGR of 8.6%during the forecast period, with a market size of USD 0.55million in 2024. Immune Repertoire Sequencing sales flourished in South Africa due to expanding healthcare infrastructure, increasing investments in biotechnology.
• The Turkey Immune Repertoire Sequencing market is projected to witness growth at a CAGR of 7.1% during the forecast period, with a market size of USD 0.30million in 2024.
• The Nigeria Immune Repertoire Sequencing market is projected to witness growth at a CAGR of 6.7%during the forecast period, with a market size of USD 0.36million in 2024.
• The Rest of the MEA Immune Repertoire Sequencing market is projected to witness growth at a CAGR of 6.6%during the forecast period, with a market size of USD 0.41million in 2024.

Immune Repertoire Sequencing Market Analysis

How are Segments Performing in the Global Immune Repertoire Sequencing Market?

Immune Repertoire Sequencing Market Product Type Segment Analysis

According to Cognitive Market Research, the Assay Kits segment holds a dominant position. Assay kits are essential tools used for immune profiling, offering reliable and precise results for researchers and healthcare professionals. With their convenience, accuracy, and ease of use, assay kits are favored for a variety of applications, including cancer research, autoimmune disease studies, and vaccine development.

The Instruments segment is experiencing rapid growth in the Immune Repertoire Sequencing Market. Advances in sequencing technology and increasing research investments are driving the demand for more sophisticated instruments. These instruments, which include high-throughput sequencers and associated hardware, enable the detailed analysis of immune systems, facilitating more accurate and faster data generation.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Immune Repertoire Sequencing Industry. Request a Free Sample PDF!

Immune Repertoire Sequencing Market Application Segment Analysis

According to Cognitive Market Research, the Cancer Immunotherapy stands as the dominant application. The growing need for personalized cancer treatment has driven significant advancements in immune profiling, enabling better-targeted therapies. Sequencing technologies offer crucial insights into the immune system's response to cancer, guiding the development of novel immunotherapies.

The Vaccine Development and Efficacy segment is the fastest-growing application in the Immune Repertoire Sequencing Market. With the rise of emerging infectious diseases and global vaccination efforts, immune repertoire sequencing is becoming essential for evaluating vaccine responses and optimizing vaccine designs. By profiling immune responses, researchers can assess efficacy, predict responses in different populations, and monitor vaccine-induced immunity.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Immune Repertoire Sequencing End-User Outlook: Segment Analysis

Immune Repertoire Sequencing Market End-User Segment Analysis

According to Cognitive Market Research, The Biotechnology and Pharmaceutical Companies represent the dominant end-user segment. These companies are heavily involved in the development of novel therapies, including immunotherapies and vaccines, where immune profiling plays a critical role. The need for precise immune system analysis to guide drug development and improve therapeutic outcomes has made this segment the largest consumer of immune repertoire sequencing technologies.

The Academic and Research Institutes segment is the fastest-growing end-user category in the Immune Repertoire Sequencing Market. With increasing funding and a surge in immunology research, academic institutions are adopting immune sequencing technologies to explore the complexities of the immune system. These institutes focus on both basic research and clinical studies, making significant contributions to understanding immune responses in diseases like cancer and autoimmune disorders.

• Diagnostics Labs
• Biotechnology and Pharmaceuticals Companies
• Academic and Research Institutes
• Others

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion